Open AccessThe effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
Author(s) -
Muhammet Bulut,
Kemal Nişli,
Aygün Dindar
Publication year - 2020
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/apc.apc_56_19
Subject(s) - medicine , apheresis , familial hypercholesterolemia , hyperlipidemia , adverse effect , ldl apheresis , concomitant , coronary artery disease , cholesterol , single center , cardiology , gastroenterology , endocrinology , platelet , diabetes mellitus
Familial hypercholesterolemia (FH) is characterized by severe hypercholesterolemia that can result in coronary artery disease occurring at an early age. If patients are not cured with lipid-lowering drugs and diets, lipid apheresis may be an effective treatment option in these cases. Here, we evaluate the efficacy, selectivity and safety of the DALI apheresis technique.